For research use only
| Cat No. | ABC-TC3645 |
| Product Type | Hepatic Cells |
| Cell Type | Stellate Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Liver |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human Hepatic Stellate Cells enable hepatic fibrosis modeling, extracellular matrix deposition analysis, and liver disease mechanism research in vitro.
Human Hepatic Stellate Cells (hHSCs) are primary mesenchymal cells isolated from adult human liver tissue, representing a key component of hepatic non-parenchymal cell population. These perisinusoidal cells are characterized by their quiescent state under physiological conditions, characterized by cytoplasmic lipid droplets rich in vitamin A—storing over 80% of the body’s retinoid reserves. These cells are cryopreserved at early passages, ensuring high viability and minimal phenotypic drift. hHSCs play essential roles in maintaining extracellular matrix (ECM) homeostasis, regulating vitamin A metabolism, and modulating hepatic microcirculation through interactions with endothelial cells and hepatocytes. hHSCs express molecular markers including desmin, glial fibrillary acidic protein (GFAP), and collagen type I alpha 1 chain (COL1A1). Upon actvation, hHSCs upregulate α-smooth mucle actin (α-SMA) and connective tissue growth factor (CTGF), hallmark features of transdifferentiation associated with liver injury and fibrosis.
| Species | Human |
| Cat.No | ABC-TC3645 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Stellate Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Liver |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Hepatic Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Hepatic Stellate Cells (HHSC) are highly relevant for a broad range of in vitro applications, including hepatotoxicity assessment, drug screening, and metabolism profiling. Their unique physiological characteristic makes them invaluable for investigating liver function, hepatic microenvironment dynamics, and liver disease progression. Additionally, gaining a deeper understanding of the molecular mechanisms behind HHSC activation is critical for developing innovative therapeutic approaches in treating hepatic fibrosis, potentially reducing morbidity and mortality rates among patients suffering from chronic liver injuries.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Hepatic Stellate Cells are provided at passage 1 (P1) and can generally be expanded for 3–5 passages under AcceGen’s recommended culture conditions.